CompanyDrug

China Resources Double-Crane Gains Approval for Definity in China

CompanyDeals

XtalPi Partners with CK Life Sciences to Develop AI Cancer Vaccine Platform

CompanyDrug

Bliss Bio’s BB-1709 Accepted for Review by China’s CDE

CompanyDeals

Xiling Lab Raises RMB 100 Million for ADC Development and IND Filing

CompanyDeals

PrimeLink Bio Raises Funds for ADC Development and R&D Expansion

CompanyMedical Device

AnchorDx’s UriFind Receives Breakthrough Therapy Designation for Urothelial Carcinoma

CompanyDeals

Visen Pharmaceuticals Files for Hong Kong IPO with Focus on Growth Hormone

CompanyDrug

Junshi Biosciences Files for UK Approval of PD-1 Inhibitor Tuoyi

Company

CSPC Pharmaceutical Reports Q3 2022 Financials with 13.8% Revenue Growth

CompanyPolicy / Regulatory

Tianjin Tianyao Fined for Anti-Monopoly Violations in Carmustine Sales

Policy / Regulatory

China Releases Third Batch of VAT Discounts for Anti-Tumor and Rare Disease Drugs

CompanyDeals

OrbusNeich Files for IPO on Hong Kong Stock Exchange